Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Labar

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
Treatment of chronic GVHD with extracorporeal photochemotherapyI Bojanic, R Serventi Seiwerth, B Golubic Cepulic, et al.
Journal of Hematotherapy & Stem Cell Research|January 25, 2000
Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypesM Sucić, D Boban, M Marković-Glamocak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience)I Radman, N Basić, B Labar, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Bone Marrow Transplantation|July 24, 2008
Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach ProgrammeJ Wachowiak, M Labopin, M Miano, et al.
British Journal of Haematology|September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoS Keating, T de Witte, S Suciu, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
Bone Marrow Transplantation|December 2, 2008
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity reportM D Aljurf, S Z Zaidi, H El Solh, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 2, 2013
Treatment of chronic GVHD with extracorporeal photochemotherapyI Bojanic, R Serventi Seiwerth, B Golubic Cepulic, et al.
Journal of Hematotherapy & Stem Cell Research|January 25, 2000
Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypesM Sucić, D Boban, M Marković-Glamocak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience)I Radman, N Basić, B Labar, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Bone Marrow Transplantation|July 24, 2008
Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach ProgrammeJ Wachowiak, M Labopin, M Miano, et al.
British Journal of Haematology|September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoS Keating, T de Witte, S Suciu, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
Bone Marrow Transplantation|December 2, 2008
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity reportM D Aljurf, S Z Zaidi, H El Solh, et al.
Pageof 12